SCHEMBL23959253

SCHEMBL23959253

c1ccc(-c2nc3ncc(-n4c5ccccc5c5cc(N(c6ccccc6)c6ccccc6)ccc54)cn3c2-c2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 6/20 0.38
▸ AKT2 P31751 6/20 0.38
▸ ROCK2 O75116 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ RAC2 P15153 1/20 0.32
▸ RAC3 P60763 1/20 0.32
▸ CDC42 P60953 1/20 0.32
▸ RAC1 P63000 1/20 0.32
▸ NPY5R Q15761 1/20 0.31
▸ L3MBTL1 Q9Y468 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959230 0.97 AKT1 (0.40) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959245 0.91 AKT1 (0.46) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959229 0.87 AKT1 (0.42) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959103 0.87 AKT1 (0.46) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959246 0.87 AKT1 (0.48) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959243 0.85 AKT1 (0.43) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959259 0.84 AKT1 (0.38) AKT1AKT2
SCHEMBL23959232 0.83 AKT1 (0.48) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959222 0.82 AKT2 (0.40) AKT1AKT2
SCHEMBL23959101 0.81 AKT1 (0.47) AKT1AKT2ROCK2PIM1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885ROCK2 2074/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885ROCK2 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback